血液透析治疗的急性并发症及处理

被引:27
作者
左力
王梅
机构
[1] 北京大学第一医院肾脏内科
关键词
肾透析/并发症; 治疗;
D O I
暂无
中图分类号
R459.5 [透析疗法];
学科分类号
摘要
引用
收藏
页码:1109 / 1110
页数:2
相关论文
共 7 条
[1]  
Impact of profile haemodialysis on intra - extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment. Ebel H,Laage C,Keuchel M,et al. Nephron . 1997
[2]  
ARTIFICIAL ORGANS[P]. ODAKA MICHIO.日本专利:JPS5223891A,1977-02-23
[3]  
First- use reactions during hemodialysis: a definition of subtypes. Daugirdas JT,Ing TS. Kidney International Supplement . 1988
[4]  
Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial. Wolkotte C,Hassell DR,Moret K,et al. Kidney International . 2002
[5]  
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with N69 membranes. Verresen L,Fink E,Lemke HD,et al. Kidney International . 1994
[6]  
Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. Cruz DN,Mahnensmith RL,Brickel HM,et al. American Journal of Kidney Diseases . 1999
[7]  
Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Cruz DN,Mahnensmith RL,Brickel HM,et al. Clinical Nephrology . 1998